ReviewCureus2026
Efficacy and Safety of Balloon Dilatation of the Eustachian Tube in Children With Eustachian Tube Dysfunction: A Systematic Review and Meta-Analysis.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The meta-analysis and systematic review evaluated the efficacy and safety of balloon dilatation of the eustachian tube (BDET) in children with eustachian tube dysfunction. The PubMed, Cochrane Library, and ScienceDirect databases were searched in depth to identify relevant studies, and eight retrospective cohort studies were selected. A total of 652 patients were included in these studies. There were no serious complications, and only minor, self-limiting adverse events were seen, the most common of which were epistaxis and a patulous eustachian tube. The primary result was an improvement in the type of tympanogram, and the secondary results were the risk of failure and complications. The pooled analysis of seven studies showed that 64% (95%CI: 50-78%) of cases demonstrated improvement in tympanogram following BDET. However, heterogeneity was high (I² = 90.7%). The pooled failure rate, based on four studies, was 13% (95%CI: 1-17%). Although the evidence on the efficacy and safety of BDET in pediatric patients is encouraging, the overall quality of evidence is limited by the retrospective nature of the included studies, the absence of control groups, and inconsistent outcome measures. These results indicate that BDET may be a useful, minimally invasive procedure for treating eustachian tube dysfunction in children. However, more specific randomized controlled trials with standardized outcome measures are needed to clarify the treatment's long-term effectiveness and its role in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.